Ae Wealth Management LLC Eli Lilly & CO Transaction History

Ae Wealth Management LLC

  • $9.76 Billion
  • Q3 2024

A detailed history of Ae Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ae Wealth Management LLC holds 73,218 shares of LLY stock, worth $56.2 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
73,218
Previous 63,613 15.1%
Holding current value
$56.2 Million
Previous $57.6 Million 12.63%
% of portfolio
0.66%
Previous 0.64%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$772.14 - $960.02 $7.42 Million - $9.22 Million
9,605 Added 15.1%
73,218 $64.9 Million
Q2 2024

Aug 12, 2024
BUY
$724.87 - $909.04 $4.82 Million - $6.04 Million
6,647 Added 11.67%
63,613 $57.6 Million
Q1 2024

May 15, 2024
SELL
$592.2 - $792.28 $20.6 Million - $27.6 Million
-34,821 Reduced 37.94%
56,966 $44.3 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $4.81 Million - $5.67 Million
9,161 Added 11.09%
91,787 $53.5 Million
Q3 2023

Oct 11, 2023
SELL
$434.7 - $599.3 $132,583 - $182,786
-305 Reduced 0.37%
82,626 $44.4 Million
Q2 2023

Jul 10, 2023
BUY
$350.74 - $468.98 $9.19 Million - $12.3 Million
26,195 Added 46.17%
82,931 $38.9 Million
Q1 2023

Apr 14, 2023
BUY
$310.63 - $364.82 $3.94 Million - $4.63 Million
12,694 Added 28.82%
56,736 $19.5 Million
Q4 2022

Jan 31, 2023
BUY
$321.55 - $374.67 $835,386 - $973,392
2,598 Added 6.27%
44,042 $16.1 Million
Q3 2022

Oct 25, 2022
BUY
$296.48 - $337.87 $1.8 Million - $2.05 Million
6,056 Added 17.11%
41,444 $13.4 Million
Q2 2022

Aug 03, 2022
BUY
$278.73 - $327.27 $498,926 - $585,813
1,790 Added 5.33%
35,388 $11.5 Million
Q1 2022

Apr 18, 2022
BUY
$234.69 - $291.66 $123,446 - $153,413
526 Added 1.59%
33,598 $9.62 Million
Q4 2021

Jan 20, 2022
BUY
$224.85 - $279.04 $1.33 Million - $1.65 Million
5,896 Added 21.7%
33,072 $9.14 Million
Q3 2021

Nov 01, 2021
BUY
$221.6 - $272.71 $351,457 - $432,518
1,586 Added 6.2%
27,176 $6.28 Million
Q2 2021

Jul 21, 2021
BUY
$180.55 - $233.54 $743,866 - $962,184
4,120 Added 19.19%
25,590 $5.87 Million
Q1 2021

Apr 27, 2021
BUY
$164.32 - $212.72 $465,354 - $602,423
2,832 Added 15.19%
21,470 $4.01 Million
Q4 2020

Feb 01, 2021
BUY
$130.46 - $172.63 $132,416 - $175,219
1,015 Added 5.76%
18,638 $3.15 Million
Q3 2020

Nov 06, 2020
BUY
$146.22 - $169.13 $495,685 - $573,350
3,390 Added 23.82%
17,623 $2.61 Million
Q2 2020

Aug 05, 2020
SELL
$136.42 - $164.18 $994,911 - $1.2 Million
-7,293 Reduced 33.88%
14,233 $2.34 Million
Q1 2020

May 07, 2020
BUY
$119.05 - $147.35 $345,245 - $427,315
2,900 Added 15.57%
21,526 $2.99 Million
Q4 2019

Jan 15, 2020
BUY
$106.92 - $132.43 $417,629 - $517,271
3,906 Added 26.54%
18,626 $2.45 Million
Q3 2019

Nov 05, 2019
BUY
$106.79 - $116.16 $106,683 - $116,043
999 Added 7.28%
14,720 $1.65 Million
Q2 2019

Jul 22, 2019
BUY
$110.79 - $129.32 $746,059 - $870,840
6,734 Added 96.38%
13,721 $1.52 Million
Q1 2019

May 14, 2019
BUY
$111.31 - $131.02 $234,530 - $276,059
2,107 Added 43.18%
6,987 $907,000
Q4 2018

Feb 15, 2019
SELL
$105.9 - $118.64 $6,671 - $7,474
-63 Reduced 1.27%
4,880 $565,000
Q3 2018

Nov 14, 2018
BUY
$85.86 - $107.31 $424,405 - $530,433
4,943 New
4,943 $530,000
Q2 2018

Aug 15, 2018
SELL
$75.7 - $86.88 $1.03 Million - $1.18 Million
-13,615 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$74.21 - $87.6 $1.01 Million - $1.19 Million
13,615 New
13,615 $1.05 Million
Q4 2017

Feb 06, 2018
SELL
$81.94 - $87.89 $1.13 Million - $1.21 Million
-13,759 Closed
0 $0
Q3 2017

Nov 08, 2017
BUY
$77.07 - $85.54 $29,132 - $32,334
378 Added 2.82%
13,759 $1.18 Million
Q2 2017

Aug 14, 2017
BUY
N/A
13,381
13,381 $1.1 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email